Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Ribbon symbolism Stories

2013-12-11 12:05:10

Women with HER2-positive breast cancer who had the highest levels of immune cells in their tumors gained the most benefit from presurgery treatment with chemotherapy and trastuzumab, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14. "We have previously shown that high levels of tumor-infiltrating lymphocytes [immune cells in a tumor] are predictive of response to trastuzumab and chemotherapy administered after surgery for early-stage,...

2013-12-11 12:02:49

Results from the initial analysis of event-free and overall survival for patients enrolled in the randomized, phase III Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimization (NeoALTTO) trial are to be presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10–14. "NeoALTTO is a randomized, phase III clinical trial evaluating whether a combination of two HER2-targeted therapies, trastuzumab and lapatinib, given with standard paclitaxel chemotherapy before...

2013-12-10 23:25:18

Ability to customize radiation therapy improves patient safety & quality. Aliso Viejo, Calif. (PRWEB) December 10, 2013 Cianna Medical, Inc., a women’s health company, today announced the outcomes of a large, retrospective study demonstrating the safety and efficacy of the SAVI® breast brachytherapy applicator. Researchers reported favorably low recurrence rates, high rates of survival and excellent cosmetic outcomes. SAVI is a strut-based applicator that delivers a form of...

2013-12-09 12:27:56

Use of Internet-based tools shown to help guide therapeutic decisions RESTON, Va, Dec. 9, 2013 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), the leading provider of clinical educational content and technological learning platforms, will deliver a poster presentation at the 2013 San Antonio Breast Cancer Symposium (SABCS) taking place December 10-14. The abstract (#P1-12-01) is entitled, "Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for...

2013-12-09 12:25:53

Quest and Alamo Breast Cancer Foundation also Co-Hosting Panel on "Cancer and BRCA Testing in the News, the Arts and Popular Culture," Joined by Director of Upcoming Film "Decoding Annie Parker" MADISON, N.J., Dec. 9, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that BRCAvantage(TM), a service-rich oncology offering designed to increase access to BRCA testing for at-risk patients and maximize the value...

2013-12-09 12:25:21

UTRECHT, The Netherlands, December 9, 2013 /PRNewswire/ -- Dutch couple invents improved cooling cap to support more cancer patients An improved scalp cooling cap worn during chemotherapy can help those with cancer avoid hair loss during their treatment. The new ChemoHairSaver has been developed by Dutch couple Arie and Caroline van Wijngaarden after Caroline was herself treated for breast cancer. Their patented invention is applauded by oncologists, hospitals,...

2013-12-05 23:30:27

Ella Health, an innovative provider of 3D mammography and other women's health services has appointed two top women executives to its Board of Directors. Sharon Knight, Patient Engagement Solutions Leader with AVIA, and Mary Ann Tocio, President and Chief Operating Officer of Bright Horizons Family Solutions, will serve as key advisors as Ella Health expands. San Francisco, CA (PRWEB) December 05, 2013 Ella Health, a 3-D mammography and women’s health services provider, has...

2013-12-05 23:02:09

VolparaDensity Volumetric Breast Density Software from Matakina Correlated to MRI in Independent Research Chicago, IL (PRWEB) December 05, 2013 RSNA: A study published yesterday by researchers at the University of California San Francisco (UCSF) in PLOS ONE journal, has provided further validation for automated volumetric breast density software. Volumetric density techniques were found to compare well with breast MRI results, with substantial agreement reported. The value of volumetric...

2013-12-05 23:02:00

Avestée Women’s Imaging Center of Alamo Heights is one of the few imaging centers in San Antonio to offer 3D mammograms at no additional cost for patients. San Antonio, TX (PRWEB) December 05, 2013 Avestée Women’s Imaging Center of Alamo Heights is one of the few imaging centers in San Antonio to offer 3D Digital Breast Tomosynthesis technology as part of its comprehensive breast imaging services. Unlike other facilities in the area, there is no additional cost for 3D...

2013-12-05 14:20:59

Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an...